Cite
MLA Citation
Hanna K. Sanoff et al.. “Multicenter, randomized, double‐blind phase 2 trial of FOLFIRI with regorafenib or placebo as second‐line therapy for metastatic colorectal cancer.” Cancer, vol. 124, no. 15, 2018, pp. 3118–3126. http://access.bl.uk/ark:/81055/vdc_100090052428.0x00005d